NanoenTekInc

039860 · KQ · Technology / Scientific & Technical Instruments

4,175.00KRW-55.00 (-1.30%)

Price History

Full chart

Market Stats

Previous Close4,230.00

Open4,240.00

Day Range4,170.00 – 4,395.00

52-Week Range3,015.00 – 9,390.00

Volume181.66K

Market Cap172.94B

P/E (TTM)0.00

Forward P/E0.00

Dividend Yield0.00%

Beta0.74

50-Day Avg3,982.00

200-Day Avg4,841.38

About

NanoEntek, Inc. engages in the research and development, production, and sale of life-science lab equipment, in vitro diagnostic medical devices, point of care diagnostic devices, and related consumables and solutions in Korea and internationally. It provides FREND system, a fluorescence immunoassay analyzer; BUDDI, a rapid diagnostic test analyzer; rapid diagnostic test items; ADAM-rWBC, a residual white blood cell counters; ADAMII/fluorescence stem cell counter; fluorescence cell counters and cell analyzers; brightfield cell counters; somatic cell counters; live-cell imaging system; and disposable hemocytometers. The company also provides digital healthcare services integrating artificial intelligence and big data technologies. The company was founded in 1987 and is headquartered in Seoul, South Korea.

Company Details

SectorTechnology
IndustryScientific & Technical Instruments
CEOMr. Jin-Hyung Park
Employees141
Headquarters5, Digital-ro 26-gil, Seoul, South Korea, 08389, Korea
Websitehttps://www.nanoentek.com

Leadership

Mr. Jin-Hyung ParkChief Executive Officer and Director · b. 1967
Mr. Jung-Goo SeoVice-President and Director · b. 1962

Financials

Income Statement

Currency: KRW	2007-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	11.12B	13.15B	13.44B	19.08B	19.50B	24.84B	22.21B	23.81B	25.80B	26.26B	29.44B	35.78B	35.20B	26.84B	30.46B	38.13B
Growth (%)	-	+18.32%	+2.14%	+42.05%	+2.17%	+27.39%	-10.60%	+7.22%	+8.35%	+1.78%	+12.14%	+21.54%	-1.63%	-23.76%	+13.52%	+25.16%
Cost of Revenue	6.88B	11.85B	11.60B	12.97B	13.10B	18.76B	17.42B	13.43B	14.60B	13.55B	15.10B	18.09B	18.29B	14.49B	13.43B	15.74B
Gross Profit	-	-	-	-	5.44B	6.08B	4.79B	10.38B	11.20B	12.71B	14.34B	17.69B	16.91B	12.34B	17.04B	22.39B
Gross Margin	-	-	-	-	27.91%	24.49%	21.57%	43.61%	43.41%	48.40%	48.70%	49.43%	48.04%	45.99%	55.92%	58.71%
Operating Expense	-	-	-	-	8.03B	14.09B	19.46B	9.75B	8.32B	10.49B	11.47B	13.65B	12.53B	14.57B	16.42B	21.29B
Operating Income	-	-	-	-	-2.59B	-8.01B	-14.67B	634.88M	2.88B	2.21B	2.87B	4.04B	4.38B	-2.23B	620.87M	1.10B
Operating Margin	-	-	-	-	-13.29%	-32.23%	-66.06%	2.67%	11.15%	8.43%	9.73%	11.28%	12.45%	-8.31%	2.04%	2.89%
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	7.97B	1.36B	6.39B	4.52B
EBITDA Margin	-	-	-	-	-	-	-	-	-	-	-	-	22.64%	5.07%	20.97%	11.86%
Net Income	-	-	-	-	-2.46B	-7.28B	-14.80B	-2.07B	3.31B	5.75B	2.74B	7.32B	4.66B	-3.68B	3.59B	1.58B
Net Income Margin	-	-	-	-	-12.64%	-29.32%	-66.64%	-8.70%	12.82%	21.90%	9.29%	20.46%	13.25%	-13.71%	11.77%	4.14%
R&D	-	2.32B	-	3.07B	739.69M	1.33B	2.11B	1.38B	1.24B	1.52B	2.45B	2.97B	3.55B	3.69B	3.56B	3.63B
R&D as % of Total Revenue	-	17.67%	-	16.08%	3.79%	5.36%	9.51%	5.78%	4.81%	5.79%	8.34%	8.29%	10.09%	13.75%	11.68%	9.51%
Interest Expense	0	0	0	0	0	0	0	0	0	8.47M	11.24M	16.41M	18.03M	15.96M	11.60M	46.82M
Interest Expense % of Total Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.03%	0.04%	0.05%	0.05%	0.06%	0.04%	0.12%

Balance Sheet

Currency: KRW	2007-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	30.46B	49.65B	44.44B	44.80B	43.26B	52.69B	45.71B	42.37B	42.16B	46.64B	52.82B	62.46B	63.28B	58.58B	79.01B	98.01B
Total Liabilities	7.11B	20.90B	21.46B	21.23B	7.76B	14.28B	20.13B	18.64B	7.01B	5.61B	7.33B	10.11B	5.63B	4.99B	5.01B	7.03B
Total Equity	23.35B	28.75B	22.98B	23.58B	35.50B	38.41B	25.58B	23.73B	35.15B	41.03B	45.49B	52.34B	57.65B	53.59B	73.99B	90.98B
Cash	3.27B	3.03B	2.29B	4.87B	1.80B	1.57B	1.65B	2.18B	1.23B	771.85M	4.23B	9.31B	11.30B	5.93B	3.39B	10.28B
Total Debt	-	-	-	-	-	3.20B	24.57B	-	-	-	460.73M	-	-	-	-	-

Cash Flow

Currency: KRW	2007-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	-	-	-	-	2.07B	-1.63B	-3.54B	-3.02B	1.71B	1.51B	4.08B	5.70B	9.29B	8.04B	-645.79M	-2.46B	4.15B
Investing Cash Flow	-	-	-	2.93B	715.88M	-1.35B	-1.14B	-4.18B	-745.31M	-1.60B	-1.01B	-9.68B	-2.94B	-4.64B	-9.28B	-15.14B	-
Financing Cash Flow	2.69B	-	22.98B	43.86M	-	-117.64M	10.51B	8.62B	-3.00B	-3.00B	-94.57M	1.10B	-177.26M	-215.21M	-299.78M	17.21B	-
Capital Expenditure	2.92B	0	1.41B	4.11B	663.34M	248.35M	5.19B	4.19B	966.53M	536.56M	840.73M	1.08B	2.56B	4.52B	1.34B	2.27B	2.11B
Free Cash Flow	-	-	-	-	-	-	-	-	-	-	-	4.01B	6.39B	3.52B	-1.98B	-4.73B	2.04B
FCF to OCF	-	-	-	-	-	-	-	-	-	-	-	70.30%	68.83%	43.80%	306.74%	192.46%	49.11%

Earnings

Report Date	Apr 21, 2005	Aug 9, 2005	Nov 2, 2010	Mar 2, 2011	May 16, 2011	Aug 31, 2011	Nov 1, 2011	Feb 29, 2012	May 14, 2012	Aug 29, 2012	Oct 30, 2012	Feb 27, 2013	May 13, 2013	Aug 28, 2013	Oct 29, 2013	Feb 26, 2014	May 12, 2014	Sep 3, 2014	Oct 28, 2014	Feb 25, 2015	May 11, 2015	Sep 2, 2015	Oct 27, 2015	Mar 2, 2016	May 16, 2016	Aug 12, 2016	Nov 11, 2016	Mar 7, 2017	May 10, 2017	Aug 10, 2017	Nov 14, 2017	Mar 8, 2018	May 15, 2018	Aug 14, 2018	Oct 31, 2018	Mar 6, 2019	May 13, 2019	Aug 13, 2019	Nov 14, 2019	May 13, 2020	Aug 12, 2020	Nov 12, 2020	May 14, 2021	Aug 17, 2021	Nov 18, 2021	May 18, 2022	Aug 16, 2022	Nov 14, 2022	Mar 1, 2023	May 15, 2023	Aug 15, 2023	Nov 15, 2023	Feb 28, 2024	May 13, 2024	Aug 14, 2024	Nov 14, 2024	Feb 26, 2025	Mar 31, 2025	Jun 30, 2025	Sep 30, 2025	Dec 31, 2025	Mar 31, 2026	Jun 30, 2026
EPS Estimate	72.70	76.40	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EPS Actual	70.56	-343.89	-66.22	-290.00	-62.81	-134.62	-73.13	-370.37	-49.27	-46.70	-76.25	-157.64	-61.79	-19.98	-29.30	47.28	-50.63	-49.18	-41.83	26.03	-56.79	-45.84	-58.50	-145.85	-114.07	-123.07	-74.50	-294.71	-38.24	13.75	17.00	-77.21	19.40	44.15	38.86	26.65	0.55	67.34	71.61	53.94	6.44	8.43	118.33	72.54	34.88	70.13	70.02	92.45	-58.59	-10.44	-68.14	-50.93	-7.69	20.97	18.00	-8.61	86.07	11.64	-33.99	19.72	49.73	38.22	55.96
Surprise	-2.94%	-550.12%	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Timing	Pre-market	Pre-market	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	Pre-market	Pre-market	After-hours	Pre-market	After-hours	Pre-market	After-hours	Pre-market	Pre-market	After-hours	After-hours	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Key Statistics & Ratios

Market Cap172.94B

Enterprise Value111.22B

Trailing P/E0.00

Forward P/E0.00

Price / Sales3.91

Price / Book1.69

Revenue (TTM)44.19B

Gross Profit (TTM)26.62B

EBITDA5.51B

Profit Margin13.26%

Operating Margin5.50%

Return on Equity6.99%

Return on Assets1.17%

Shares Outstanding37.84M

Shares Float22.13M

Beta0.74

Dividend Yield0.00%

Dividend Rate0.00

Payout Ratio0.00%

Dividends

20031×

50.00Dec 29, 2003

20011×

100.00Jan 2, 2001